NAD+, NMN, and NR tend to get bundled together, but they are not the same thing. NAD+ is a molecule your cells use for energy metabolism, DNA repair, and other cellular processes. NMN and NR are vitamin B3-related compounds your body can use to make NAD+.

So, if you're choosing a supplement, the more useful debate is NMN vs NR, not really NAD vs NR.

And there is finally some good head-to-head human data. In a 2026 study, taking 1,000 mg of NMN or 1,000 mg of NR daily for 14 days roughly doubled whole-blood NAD+ levels. Neither came out as the clear winner. (1)

Key takeaways:

• NMN and NR both raise blood NAD+. A direct 2026 human trial found very similar effects at 1,000 mg per day. (1)

• NMN being one biochemical step closer to NAD+ doesn't mean it works better. Human metabolism appears more complicated than that.

• NR has been studied in humans for longer, while human NMN research has grown considerably in recent years.

• Raising NAD+ is not the same as proving anti-aging benefits. A 2026 systematic review found that clinical effects remain mixed. (2)

NAD vs NR vs NMN at a glance

The basic pathway is commonly shown like this:

NR → NMN → NAD+

That diagram is useful, but it leaves out quite a bit.

How are NR, NMN, and NAD+ connected?

NAD+, short for nicotinamide adenine dinucleotide, works inside cells as a coenzyme. Your body needs it for hundreds of biochemical reactions, including energy production and the activity of enzymes involved in cellular repair.

NR, or nicotinamide riboside, can enter the NAD+ salvage pathway and form NMN before NAD+. That makes NMN look like it has a shortcut.

For years, this became one of the main arguments for choosing NMN over NR. NMN is one step away from NAD+, while NR needs another conversion first.

Human research now suggests the story is less tidy.

A 2026 trial found evidence that both orally consumed NR and NMN interact substantially with gut microbes. Researchers proposed that gut bacteria convert part of both compounds into nicotinic acid, which can then contribute to NAD+ production through another pathway known as the Preiss-Handler pathway. (1)

In other words, counting biochemical steps on a diagram doesn't tell us which supplement works better inside a person.

NMN vs NR: Which raises NAD+ more?

Right now, human evidence does not show a clear winner between NMN and NR for raising whole-blood NAD+.

That conclusion comes from a particularly useful 2026 study because researchers compared them directly instead of studying each supplement separately.

The randomized trial included 65 healthy adults who received placebo, nicotinamide, NR, or NMN for 14 days. The NR and NMN doses were both 1,000 mg per day. (1)

Compared with placebo, whole-blood NAD+ increased by:

• 49.4 μM with NR

• 43.1 μM with NMN

Both represented roughly a twofold increase from baseline. Researchers concluded that NR and NMN were comparable in their ability to increase baseline whole-blood NAD+. (1)

That's an important update to the NR vs NMN debate.

It also doesn't mean NR is 14.6% "better" because its numerical increase was slightly higher. The study wasn't evidence of a clinically meaningful advantage for NR over NMN.

More importantly, blood NAD+ is a biomarker. Doubling it does not automatically mean someone will live longer, feel younger, improve their metabolism, or avoid age-related disease.

NMN or NR: What does human research say about the benefits?

This is where the evidence gets more interesting, and less clean.

A 2026 systematic review identified 33 human intervention studies, including 28 randomized trials, involving NAD+-related compounds. The researchers found that oral NMN and NR consistently affected NAD-related biomarkers and were generally well tolerated over periods of weeks to months. (2)

Health outcomes were much less consistent.

What have NMN studies found?

One well-known randomized trial studied postmenopausal women with overweight or obesity and prediabetes.

After 10 weeks, NMN improved skeletal-muscle insulin sensitivity and insulin signaling compared with placebo. It did not produce the same improvements across every metabolic measurement, though. (3)

That makes it an interesting result, rather than proof that NMN improves metabolic health for everyone.

What have NR studies found?

NR also has solid evidence for changing NAD+ metabolism.

A randomized crossover trial in healthy middle-aged and older adults found that six weeks of NR supplementation increased NAD+ metabolism and was well tolerated. (4)

Another study paints a more cautious picture.

Forty men with obesity and insulin resistance received 2,000 mg of NR per day for 12 weeks. NR was well tolerated, but it did not improve insulin sensitivity, glucose metabolism, resting energy expenditure, or body composition compared with placebo. (5)

So neither side has a clean knockout punch.

The broader human research suggests NMN and NR can both influence NAD+ biology, but raising NAD+ has not yet translated into consistent improvements in health, physical performance, or aging-related outcomes. (2)

NAD vs NR: Is taking NAD+ directly better?

Not based on the evidence we have. Taking NAD+ itself and taking NR are also quite different approaches.

NR is a precursor that enters pathways your body uses to produce NAD+. Direct NAD+ has gained attention largely through IV therapies, where NAD+ is infused into the bloodstream.

Clinical evidence supporting those treatments is limited.

A 2026 retrospective study compared four consecutive days of 500 mg IV NAD+ with 500 mg IV NR. People receiving NAD+ reported more moderate-to-severe gastrointestinal symptoms, increased heart rate, and chest pressure during infusion. Average infusion time was 97 minutes for NAD+ compared with 37 minutes for NR. (6)

There are some big caveats. It was a small retrospective study conducted in a commercial wellness setting, not a large randomized trial designed to establish which treatment works better.

More tellingly, the 2026 systematic review found no eligible clinical-outcome trials testing IV or intramuscular NAD+ itself for anti-aging or wellness purposes. (2)

Claims that IV NAD+ is superior to NR or NMN are getting ahead of the clinical evidence.

Does NAD+ really decline as we age?

You'll see a lot of precise claims online about NAD+ dropping by 50% or more as people get older. Human biology isn't quite that simple.

A 2026 Nature Metabolism study measured NAD+ across seven independent human cohorts. Whole-blood NAD+ remained surprisingly stable across age groups, leading the researchers to question its usefulness as a blood biomarker of aging. (7)

That doesn't mean aging has no effect on NAD+ biology.

Different tissues can tell different stories. Previous human research has reported age-related changes in NAD+ metabolism in tissues such as skeletal muscle.

The distinction matters. Saying "blood NAD+ inevitably falls dramatically as you age" is much stronger than the current human evidence supports.

So, NMN or NR?

If your main goal is increasing circulating NAD+, current human evidence gives us little reason to declare NMN or NR the clear winner.

Both can raise NAD+. NR has a longer history of human clinical research, while the number and quality of NMN trials have grown.

The most interesting new finding is that the first direct comparison found remarkably similar NAD+-raising effects between the two. (1)

For health benefits beyond biomarkers, patience is still needed. Some NMN and NR trials have reported promising outcomes, others have found little or no meaningful change, and neither supplement has been shown to extend human lifespan. (2)

That's a less exciting answer than declaring a winner, but it's much closer to where the science sits today.

Final words

The NMN vs NR argument has become much clearer thanks to newer human research. Both can raise NAD+, and the best direct comparison so far found very similar results.

What researchers still don't know is much bigger: how much raising NAD+ translates into meaningful improvements in long-term human health.

For people who prefer NMN, at Omre, we've paired NMN with trans-resveratrol in our NMN + Resveratrol formula, using research-led doses and third-party testing.

It's designed as a straightforward option for supporting healthy aging without turning early research into bigger promises than the science can support.

FAQs

Is NR better than NMN?

Current human evidence does not show that NR is clearly better than NMN. A 2026 head-to-head study using 1,000 mg per day found that both produced comparable increases in whole-blood NAD+. (1)

Which raises NAD+ more, NMN or NR?

Both appear effective at raising whole-blood NAD+. In the direct 2026 comparison, NR increased NAD+ by 49.4 μM versus placebo and NMN by 43.1 μM, but researchers concluded that their NAD+-raising effects were comparable. (1)

Does NMN turn into NR?

NMN does not simply need to turn into NR before becoming NAD+. NR can form NMN in the NAD+ salvage pathway. New research also suggests both supplements can undergo substantial gut microbial metabolism, including conversion into nicotinic acid. (1)

Is NAD+ better than NR?

There isn't enough clinical evidence to say direct NAD+ is better than NR. Human evidence for NR is considerably more developed, while clinical trials evaluating direct NAD+ for anti-aging or wellness outcomes remain sparse. (2)

Can you take NMN and NR together?

You can find supplements combining NAD+ precursors, but there is little human evidence showing that taking NMN and NR together works better than using either one alone. Since both feed into NAD+ metabolism, taking both shouldn't be assumed to provide an added benefit.

References

1. Christen S, et al. (2026). The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans. Nature Metabolism.

2. Gallagher C, Emmanuel OO. (2026). NAD+ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence. Aging Research Reviews.

3. Yoshino M, et al. (2021). Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science.

4. Martens CR, et al. (2018). Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature Communications.

5. Dollerup OL, et al. (2018). A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects. American Journal of Clinical Nutrition.

6. Reyna K, et al. (2026). Intravenous infusion of NAD+ versus nicotinamide riboside: a retrospective tolerability pilot study in a real-world setting. Frontiers in Aging.

7. Trętowicz MM, et al. (2026). Human whole-blood NAD+ levels do not vary with age or lifestyle interventions. Nature Metabolism.